Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
about
Ethaselen: a novel organoselenium anticancer agent targeting thioredoxin reductase 1 reverses cisplatin resistance in drug-resistant K562 cells by inducing apoptosis.EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrationsPredicting of Effective Dose as Biomarker for Cytotoxicity Using Partial Least Square-Fourier Transform Infrared Spectroscopy (PLS_FTIR).Quantitation of DNA adducts by stable isotope dilution mass spectrometry.Nuclease digestion and mass spectrometric characterization of oligodeoxyribonucleotides containing 1,2-GpG, 1,2-ApG, and 1,3-GpXpG cisplatin intrastrand cross-links.A quantitative mass spectrometry-based approach for assessing the repair of 8-methoxypsoralen-induced DNA interstrand cross-links and monoadducts in mammalian cells.DNA Adducts from Anticancer Drugs as Candidate Predictive Markers for Precision Medicine.The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA.Hyphenated techniques as tools for speciation analysis of metal-based pharmaceuticals: developments and applications.Anticancer metallodrug research analytically painting the "omics" picture--current developments and future trends.Cisplatin resistance in cell models: evaluation of metallomic and biological predictive biomarkers to address early therapy failure.Speciation of oxaliplatin adducts with DNA nucleotides.Metal-based antitumour drugs in the post-genomic era: what comes next?In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors.On the complexity and dynamics of in vivo Cisplatin-DNA adduct formation using HPLC/ICP-MS.In vitro studies on cisplatin focusing on kinetic aspects of intracellular chemistry by LC-ICP-MS.
P2860
Q33722983-CEE5DD14-C57A-4E43-ABFD-BAB91E091CF6Q36076525-271EEBC9-DB95-46E4-8E75-F7D2AD5498B0Q36358412-5B8A5754-96F7-4374-B36B-0B45823429A7Q36390390-059BF5AF-A1DD-4715-99DB-81CB494CBA61Q36763096-31D741C4-F41D-41E1-86F0-2FFD4A8FC9AFQ37056699-1EEABA7D-CDC5-4B13-B0BD-E987BA0F02CEQ37736567-13F38BC4-76EF-4002-BB35-57BA88BBE4D3Q37940370-2785C3FE-0B6B-405F-BC76-56A6110347A9Q38000483-73B11CBD-BF4C-436C-AC2E-41CFFC5FA785Q38052406-31A082B9-AC08-45D0-AD6A-20792FAA2F57Q38829177-51A97B62-BD2A-499A-8E0D-94B3D93F67F9Q39486608-992FF648-D06B-4653-AFB5-E4147715E46CQ39732756-C9E838F2-7904-4514-AB47-09E544BDDF09Q52720551-FFE25987-CFC3-4321-A576-DBAC002EF7E5Q52886835-80D6E75E-C971-4570-B8F1-A7CBE71A36F7Q53116557-8251362D-E84D-4075-963D-5F9A98A39F5B
P2860
Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Determination of cisplatin 1,2 ...... pled plasma mass spectrometry.
@en
Determination of cisplatin 1,2 ...... pled plasma mass spectrometry.
@nl
type
label
Determination of cisplatin 1,2 ...... pled plasma mass spectrometry.
@en
Determination of cisplatin 1,2 ...... pled plasma mass spectrometry.
@nl
prefLabel
Determination of cisplatin 1,2 ...... pled plasma mass spectrometry.
@en
Determination of cisplatin 1,2 ...... pled plasma mass spectrometry.
@nl
P2093
P356
P1476
Determination of cisplatin 1,2 ...... upled plasma mass spectrometry
@en
P2093
Anne L Thomas
Peter B Farmer
Rachel C Le Pla
P304
P356
10.1021/TX100023C
P577
2010-08-01T00:00:00Z